Normal Tissue Complication Probability Modeling for Proton Therapy

View at publisher Summarise with VIRAT
Authors: Mei Chen, Zhongxing X. Liao, Steven Jay Frank, Narayan Sahoo, Xiaorong Ronald Zhu, Xiaodong Zhang
Cited by: 0
References: 63

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Proton therapy requires accurate, reliable normal tissue complication probability (NTCP) models for treatment planning and evidence-based patient selection. This review examines 2 challenges in proton therapy: developing NTCP models that accurately reflect proton-specific toxicity and managing NTCP prediction uncertainty to ensure reliable clinical decision-making. Regarding model accuracy, photon-derived NTCP models work for some endpoints but fail for others when proton therapy exhibits distinct dose-response characteristics, indicating that the need for proton-specific models is endpoint-dependent. Clinical evidence that supports updating NTCP models by incorporating variable relative biological effectiveness is statistically weak due to interpatient heterogeneity and inconsistent findings. Despite ongoing efforts in improving NTCP prediction accuracy, the impact of prediction uncertainty on patient selection decisions has received limited attention. Further study is required to establish a robust, model-uncertainty-aware NTCP-guided patient selection framework for proton therapy that addresses both model accuracy and prediction confidence.

Fields of Study & Subjects

Radiation Therapy and Dosimetry Advanced Radiotherapy Techniques Effects of Radiation Exposure

Publication details

Journal / source
The Cancer Journal
Volume
32
Issue
2
Publication date
1 March 2026
Language
EN